A major European business group in China is encouraged by recent signals of further policy reforms, but says in a new report it would like to see further progress on drug and device tenders, the lifting of indirect competition restrictions, and full implementation of the central push for a level playing field for foreign firms.
Every March, thousands of officials gather in Beijing to hear the Chinese government’s policy priorities for the year ahead.
In his speech to delegates attending the so-called Lianghui (Two Sessions) this year, Premier Li Zheng touched on several health-related...